Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TACR2 Stable Cell Line

    [CAT#: S01YF-0923-KX51]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX654 Magic™ Mouse TACR2 in Vitro Calcium Flux Assay Mouse CHO-K1 Calcium Flux Assay
    S01YF-1122-KX655 Magic™ Rhesus monkey TACR2 in Vitro Calcium Flux Assay Rhesus monkey CHO-K1 Calcium Flux Assay
    S01YF-1122-KX656 Magic™ Rat TACR2 in Vitro Calcium Flux Assay Rat CHO-K1 Calcium Flux Assay

    Product Information

    Target Protein
    TACR2
    Target Family
    Tachykinin Family
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research
    Related Diseases
    Baritosis; Asthma
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Tachykinin neuropeptide substance K is a receptor for the protein TACR2, which can interact with G proteins to activate the phosphatidylinositol-calcium second messenger pathway. It also has something to do with GPCR signaling and peptide ligand-binding receptors. Recent research suggests that it is linked to a wide range of illnesses, including Asthma and Retinitis Pigmentosa 68. In actuality, TACR2 has a big impact on GI motility, secretion, and visceral sensitivity. Numerous other conditions, such as uterine leiomyomas, colorectal cancer, and Alzheimer's disease, have also been linked to the TACR2. In clinical therapy, TACR2 receptor antagonists have been used. The customized TACR2 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Elvira

    The products definitely stand out. They are an excellent investment because of their unparalleled performance and quality. Jul 28 2023

    chat Verified Customer

    chat Josephine

    We are so lucky to work with creative biolabs. The quality of work, efficiency, and speed was perfect. May 27 2023

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Human DCs induce both NK2R and TAC1 gene after IFN-g or poly I:C stimulation.

    Human DCs made from PBMC adherent cells were either left untreated (control) or given IFN-𝛾 or poly I:C for a 24-hour period. Confocal microscopy was used to compare the amounts of hNK2R protein expression in the control (left panel) and IFN-𝛾-treated (right panel) human DCs.

    Ref: Kitamura, Hidemitsu, et al. "Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor." The Journal of Immunology 188.9 (2012): 4200-4208.

    Pubmed: 22474018

    DOI: 10.4049/jimmunol.1102521

    Research Highlights

    Here, they characterize a new mouse strain with congenital Tacr2 ablation to examine the physiological roles of NK2R in controlling the reproductive axis. Similar to agonists of NK1R and NK3R, activation of NK2R in control mice induced acute luteinizing hormone (LH) responses.
    Torres, Encarnacion, et al. "Congenital ablation of Tacr2 reveals overlapping and redundant roles of NK2R signaling in the control of reproductive axis." American Journal of Physiology-Endocrinology and Metabolism 320.3 (2021): E496-E511.
    Pubmed: 33427049   DOI: 10.1152/ajpendo.00346.2020

    In vitro and in vivo, Tacr2 negatively impacted the expression of nNOS and VIP. Its ablation in mice increased the expression of nNOS and VIP, improved NO signaling, and altered the Creb and NF-κB signaling, ultimately resulting in the disruption of stomach emptying in Tacr2-/- animals.
    Mao, Y-L., et al. "Ablation of Tacr2 in mice leads to gastric emptying disturbance." Neurogastroenterology & Motility 29.11 (2017): e13117.
    Pubmed: 28585346   DOI: 10.1111/nmo.13117

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare